Lymphadenopathy surgery: Difference between revisions
Farima Kahe (talk | contribs) No edit summary |
|||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Lymphadenopathy}} | {{Lymphadenopathy}} | ||
{{CMG}}; {{AE}}{{ADS}},{{RT}} | {{CMG}}; {{AE}}{{ADS}},{{RT}}{{DYM}} | ||
==Overview== | ==Overview== | ||
Line 7: | Line 7: | ||
==Indications== | ==Indications== | ||
*Surgery is not the first-line treatment option for patients with lymphadenopathy. It depends upon the underlying diagnosis. Surgery is usually reserved for patients with either:<ref name="pmid300206222">{{cite journal |vauthors=Freeman AM, Matto P |title= Adenopathy|date= December 13, 2018 |pmid=30020622 |url=https://www.ncbi.nlm.nih.gov/books/NBK513250/#article-40409.s7}}</ref> | |||
** | *[[Surgery]] is not the first-line treatment option for patients with lymphadenopathy. It depends upon the underlying diagnosis. [[Surgery]] is usually reserved for patients with either:<ref name="pmid300206222">{{cite journal |vauthors=Freeman AM, Matto P |title= Adenopathy|date= December 13, 2018 |pmid=30020622 |url=https://www.ncbi.nlm.nih.gov/books/NBK513250/#article-40409.s7}}</ref> | ||
** | **[[Malignancy]] | ||
**[[Biopsy]] required for staging<ref name="pmid30430795">{{cite journal |vauthors=Dorfman T, Neymark M, Begal J, Kluger Y |title=Surgical Biopsy of Pathologically Enlarged Lymph Nodes: A Reappraisal |journal=Isr Med Assoc J |volume=20 |issue=11 |pages=674–678 |date=November 2018 |pmid=30430795 |doi= |url=}}</ref> | |||
==Surgery== | ==Surgery== | ||
A surgical [[biopsy]] also has its role in the clinical evaluation of patients with enlarged [[lymph nodes]]. Surgery, particularly in patients with suspected [[lymphoma]] recurrence, can significantly reduce the duration of the investigation and avoid unnecessary diagnosis.<ref name="pmid30430795">{{cite journal |vauthors=Dorfman T, Neymark M, Begal J, Kluger Y |title=Surgical Biopsy of Pathologically Enlarged Lymph Nodes: A Reappraisal |journal=Isr Med Assoc J |volume=20 |issue=11 |pages=674–678 |date=November 2018 |pmid=30430795 |doi= |url=}}</ref> | A surgical [[biopsy]] also has its role in the clinical evaluation of patients with enlarged [[lymph nodes]]. [[Surgery]], particularly in patients with suspected [[lymphoma]] recurrence, can significantly reduce the duration of the investigation and avoid unnecessary diagnosis.<ref name="pmid30430795">{{cite journal |vauthors=Dorfman T, Neymark M, Begal J, Kluger Y |title=Surgical Biopsy of Pathologically Enlarged Lymph Nodes: A Reappraisal |journal=Isr Med Assoc J |volume=20 |issue=11 |pages=674–678 |date=November 2018 |pmid=30430795 |doi= |url=}}</ref> | ||
*The feasibility of surgery depends on the underlying diagnosis. | |||
* Surgical care involves open [[biopsy]] or aspiration of the lymph node and its removal. | *The feasibility of [[surgery]] depends on the underlying diagnosis. | ||
* Lymph nodes are dissected when the cancer is in an advanced stage. | *Surgical care involves open [[biopsy]] or aspiration of the lymph node and its removal. | ||
*Lymph nodes are dissected when the cancer is in an advanced stage. | |||
==References== | ==References== |
Latest revision as of 15:36, 26 April 2021
Lymphadenopathy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Lymphadenopathy surgery On the Web |
American Roentgen Ray Society Images of Lymphadenopathy surgery |
Risk calculators and risk factors for Lymphadenopathy surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2],Raviteja Guddeti, M.B.B.S. [3]Delband Yekta Moazami, M.D.[4]
Overview
Surgery is not the first-line treatment option for patients with lymphadenopathy. Surgery is usually reserved for patients with either malignancy and an indication of biopsy. It involves the removal or aspiration of lymph nodes. They are dissected when cancer is in an advanced stage.
Indications
- Surgery is not the first-line treatment option for patients with lymphadenopathy. It depends upon the underlying diagnosis. Surgery is usually reserved for patients with either:[1]
- Malignancy
- Biopsy required for staging[2]
Surgery
A surgical biopsy also has its role in the clinical evaluation of patients with enlarged lymph nodes. Surgery, particularly in patients with suspected lymphoma recurrence, can significantly reduce the duration of the investigation and avoid unnecessary diagnosis.[2]
- The feasibility of surgery depends on the underlying diagnosis.
- Surgical care involves open biopsy or aspiration of the lymph node and its removal.
- Lymph nodes are dissected when the cancer is in an advanced stage.